Your session is about to expire
← Back to Search
Flu Vaccine for Melanoma
Study Summary
This trial will give the flu vaccine to people with different stages of melanoma to see if it has any effect on the tumor size.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 384 Patients • NCT03969641Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age limit of this clinical trial below 75 years?
"The qualifications for this trial stipulate that individuals participating must be between 18 and 90 years of age. In addition, there are 138 studies targeting patients younger than 18 and 2472 trials focusing on adults above the retirement threshold."
Is recruitment for the trial still open?
"That is accurate. The information hosted on clinicaltrials.gov affirms that the trial, which was published on October 20th 2021, is still open for enrollment and searching to recruit 36 patients at one site."
Have other investigations been conducted with Quadrivalent Inactivated Influenza Vaccine?
"Currently, there are 1686 clinical studies examining Quadrivalent Inactivated Influenza Vaccine with 204 in the most advanced stage of trials. Of these trials, the majority can be found in Houston, Texas; however, globally 74916 locations are trialing this vaccine."
How many participants are taking part in the experiment?
"Affirmative, clinicaltrials.gov records demonstrate that this research study began on October 20th 2021 and is still recruiting participants. The team needs to fill 36 open spots at one facility."
What condition is Quadrivalent Inactivated Influenza Vaccine most frequently employed to address?
"Quadrivalent Inactivated Influenza Vaccine (QIV) is typically used to treat unresectable melanoma, as well as other conditions such as microsatellite instability-high colorectal cancer and high risk of recurrence."
What are the key aims of this clinical trial?
"The primary metric of this trial, which will be monitored over a two and half months period is the incidence of adverse effects. Secondary measures comprise degree of tumor reduction (percentage), Granzyme B H-score, and NanoString Pan Cancer Immune Profiling Panel; all three being assessed via summary statistics."
Am I eligible to join this experiment?
"This trial is open to 36 qualified individuals aged 18-90 with a clinical stage iib cutaneous melanoma AJCC v8. To be eligible, they must also display an ECOG performance status of 0-1 and have at least one biopsy proven lesion measuring 1 cm or more."
Share this study with friends
Copy Link
Messenger